Imported infectious diseases : the impact in developed countries
β Scribed by Fernando Cobo MartiΜnez
- Publisher
- Woodhead Publishing, , Elsevier Ltd
- Year
- 2015
- Tongue
- English
- Leaves
- 281
- Series
- Woodhead Publishing series in biomedicine, Number 66
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
The increase of immigrant population in developed countries (mainly in Europe and North America) together with an important increase of international travel worldwide are the two most important causes that have contributed to the introduction and diagnosis of imported/tropical infectious diseases in these countries. These factors have had an important impact in developed countries in both social and economic aspects. Imported Infectious Diseases focuses not only on describing the infections, but also in evaluating the current epidemiology, the economic and social impact and the possibility to apply immunization measures and vaccines. The main purpose of this book is to give an overview of the current most important and frequent imported infectious diseases in developed countries. The first chapter informs about the medical services that are being offered to the immigrants in the main developed countries depending on the legal situation. Following chapters describe the main surveillance systems for these kinds of diseases, mainly in Europe and North America. Finally, remaining chapters contain sections on epidemiology, pathogenesis, clinical features, diagnosis, treatment and prevention.
β¦ Table of Contents
Content:
Front matter, Pages i-iii
Copyright, Page iv
List of figures, Pages xi-xii
List of tables, Pages xiii-xiv
Acknowledgements, Page xv
Preface, Page xvii
About the author, Page xix
1 - Introduction, Pages 1-8
2 - Epidemiology of infectious diseases in immigrants, Pages 9-16
3 - Surveillance systems for tropical infectious diseases in developed countries, Pages 17-26
4 - Febrile syndrome in immigrants and travellers, Pages 27-39
5 - Diarrhoea syndrome, Pages 41-59
6 - Current status of malaria, Pages 61-90
7 - Filariasis, Pages 91-114
8 - Schistosomiasis (bilharziasis), Pages 115-126
9 - Strongyloidiasis, Pages 127-135
10 - Trypanosomiasis, Pages 137-153
11 - Taeniasis and neurocysticercosis, Pages 155-166
12 - HIV infection, Pages 167-184
13 - Syphilis, Pages 185-198
14 - Tuberculosis: the problem of multiresistance, Pages 199-211
15 - Viral hepatitis, Pages 213-225
16 - Leishmaniasis, Pages 227-242
17 - Viral haemorrhagic fevers, Pages 243-255
18 - Arthropod-borne viruses affecting the central nervous system, Pages 257-262
19 - Prophylaxis, immunisation and vaccination, Pages 263-272
Index, Pages 273-277
π SIMILAR VOLUMES
Arch Mainous III, PhD, Claire Pomeroy, MD, and a panel of experienced physicians offer an eminently practical summary of the most effective evidence-based antimicrobial treatments encountered in both hospital and outpatient settings. Focusing on the clinical impact of appropriate diagnosis and treat
Arch Mainous III, PhD, Claire Pomeroy, MD, and a panel of experienced physicians offer an eminently practical summary of the most effective evidence-based antimicrobial treatments encountered in both hospital and outpatient settings. Focusing on the clinical impact of appropriate diagnosis and treat
<p><p>This book focuses on the effects of rural livelihood and the impact of infectious diseases on health and poverty. It explores cultures and traditions in developing countries and their role in infectious-disease management and prevention. It highlights the associated healthcare systems and how
Resource for the evidence-based antimicrobial treatment of infectious diseases encountered in hospital and outpatient settings. Focuses on the significant pathogens, followed by articles on their clinical management. For clinicians. DNLM: Infection--drug therapy.
<P>Recent evidence suggests an increasing rate of antimicrobial resistant pathogens throughout the world. Pathogens like Staphylococcus aureus are showing substantial prevalence of resistance to antibiotics.</P> <P>Thus, we think that given these developments, clinicians would welcome an updated ve